Sign inGet started

Poole Sandra

Insider CIK 1619622 · RTRX Director · LOGC Chief Operating Officer · IMGN Senior VP, Tech Operations

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TVTX Travere Therapeutics, Inc. A Award deriv2026-05-192026-05-2112,000— $012,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2026-05-192026-05-214,000— $034,000SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2025-05-152025-05-1619,500— $019,500SEC↗
TVTX Travere Therapeutics, Inc. A Award2025-05-152025-05-166,500— $030,000SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2024-05-082024-05-1019,500— $019,500SEC↗
TVTX Travere Therapeutics, Inc. A Award2024-05-082024-05-106,500— $023,500SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2023-05-172023-05-1913,500— $013,500SEC↗
TVTX Travere Therapeutics, Inc. A Award2023-05-172023-05-194,500— $017,000SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2022-05-112022-05-129,000— $09,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2022-05-112022-05-123,000— $012,500SEC↗
TVTX Travere Therapeutics, Inc. A Award deriv2021-05-142021-05-189,000— $09,000SEC↗
TVTX Travere Therapeutics, Inc. A Award2021-05-142021-05-183,000— $09,500SEC↗
RTRX Retrophin, Inc. A Award deriv2020-05-152020-05-199,000— $09,000SEC↗
RTRX Retrophin, Inc. A Award2020-05-152020-05-193,000— $06,500SEC↗
RTRX Retrophin, Inc. A Award deriv2019-05-132019-05-1514,000— $014,000SEC↗
RTRX Retrophin, Inc. A Award2019-05-132019-05-153,500— $03,500SEC↗
LOGC LogicBio Therapeutics, Inc A Award deriv2018-10-182018-10-22106,262— $0106,262SEC↗
LOGC LogicBio Therapeutics, Inc A Award deriv2018-10-182018-10-2477,500— $077,500SEC↗
IMGN IMMUNOGEN INC A Award deriv2016-10-192016-10-2027,500$2.26 $62.1K27,500SEC↗
IMGN IMMUNOGEN INC A Award deriv2016-07-182016-07-20110,000$3.05 $335.5K110,000SEC↗
IMGN IMMUNOGEN INC A Award deriv2015-07-132015-07-14110,000$16.72 $1.84M110,000SEC↗